Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04793867 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Regional Phenotyping of CF and Non-CF Bronchiectasis

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 9 months later Mar 31, 2026 → Dec 31, 2027
See other at-risk trials from Children's Hospital Medical Center, Cincinnati

Record History

  1. Primary completion pushed from Mar 31, 2026 to Dec 31, 2027 Lead sponsor: Children's Hospital Medical Center, Cincinnati to Children's Hospital Medical Center, Cincinnati · Completion pushed from Mar 31, 2027 to Dec 31, 2028 · Eligibility criteria expanded, about 9 words · 1 more Show 4 more changesShow less
    • Lead sponsor: Children's Hospital Medical Center, Cincinnati to Children's Hospital Medical Center, Cincinnati
    • Completion pushed from Mar 31, 2027 to Dec 31, 2028
    • Eligibility criteria expanded, about 9 words
    • Study description revised
  2. Primary completion date: Mar 2026 to Mar 31, 2026 Completion date: Mar 2027 to Mar 31, 2027 · Interventions: Xenon (Diagnostic Test) to Xenon (Drug) · Study site revisedv5 Show 3 more changesShow less
    • Completion date: Mar 2027 to Mar 31, 2027
    • Interventions: Xenon (Diagnostic Test) to Xenon (Drug)
    • Study site revised

    See this version in full on ClinicalTrials.gov ↗

  3. Study site revisedv4 See this version in full on ClinicalTrials.gov ↗
  4. Start date changed from estimate of Aug 2021 to Feb 8, 2021v3
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Mar 2021 to Aug 2021 · Study sites: 0 to 1v2 Show 2 more changesShow less
    • Start date: Mar 2021 to Aug 2021
    • Study sites: 0 to 1
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.
Trial Details
NCT Number NCT04793867
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions Cystic Fibrosis, Non-CF Bronchiectasis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov